|
| Exchange Disseminated Time 03/08/2016 15:35:24 | Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on August 11, 2016 to consider and approve, inter-alia, the following:
1. Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter ending June 30, 2016;
2. Merger of the Wholly-owned Subsidiary, M/s. Amrutanjan Pharmaessence Private Limited with M/s. Amrutanjan Health Care Limited
In view of the above, the trading window for dealing in the securities of the Company is closed for the Specified Persons (Directors & Designated Employees) from August 04, 2016 to August 15, 2016 (both days inclusive) as per Company's Code of Conduct to regulate, monitor and report trading by insiders pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. |
|
|